05-23-3800 Endothelin 1, Human and Porcine - CAS 117399-94-7 - Calbiochem

05-23-3800
Cenu nelze zjistit
Minimum Quantity needs to be mulitiple of
S dokončenou objednávkou Další informace
Ušetřili jste ()
 
Vyžádat nacenění
Omezená dostupnostOmezená dostupnost
Na skladě 
Přerušeno
Dostupné omezené množství
Dostupnost bude potvrzena
    Remaining : Will advise
      Remaining : Will advise
      Bude poskytnuto
      Kontaktujte Zákaznický servis
      Contact Customer Service
      Zobrazit ceny a dostupnost
      Klikněte pro vytištění této stránky

      Přehled

      Replacement Information

      Tabulka spec. kláve

      Empirical FormulaCAS #
      C₁₀₉H₁₅₉N₂₅O₃₂S₅ 117399-94-7

      Ceny a dostupnost

      Katalogové čísloDostupnost Balení ks/bal. Cena Množství
      05-23-3800-0.1MG
      Zjišťuji dostupnost...
      Omezená dostupnostOmezená dostupnost
      Na skladě 
      Přerušeno
      Dostupné omezené množství
      Dostupnost bude potvrzena
        Remaining : Will advise
          Remaining : Will advise
          Bude poskytnuto
          Kontaktujte Zákaznický servis
          Contact Customer Service

          Plastová ampulka .1 mg
          Zjišťuji cenu...
          Cenu nelze zjistit
          Minimum Quantity needs to be mulitiple of
          S dokončenou objednávkou Další informace
          Ušetřili jste ()
           
          Vyžádat nacenění
          05-23-3800-0.5MG
          Zjišťuji dostupnost...
          Omezená dostupnostOmezená dostupnost
          Na skladě 
          Přerušeno
          Dostupné omezené množství
          Dostupnost bude potvrzena
            Remaining : Will advise
              Remaining : Will advise
              Bude poskytnuto
              Kontaktujte Zákaznický servis
              Contact Customer Service

              Plastová ampulka .5 mg
              Zjišťuji cenu...
              Cenu nelze zjistit
              Minimum Quantity needs to be mulitiple of
              S dokončenou objednávkou Další informace
              Ušetřili jste ()
               
              Vyžádat nacenění
              05-23-3800-1MG
              Zjišťuji dostupnost...
              Omezená dostupnostOmezená dostupnost
              Na skladě 
              Přerušeno
              Dostupné omezené množství
              Dostupnost bude potvrzena
                Remaining : Will advise
                  Remaining : Will advise
                  Bude poskytnuto
                  Kontaktujte Zákaznický servis
                  Contact Customer Service

                  Plastová ampulka 1 mg
                  Zjišťuji cenu...
                  Cenu nelze zjistit
                  Minimum Quantity needs to be mulitiple of
                  S dokončenou objednávkou Další informace
                  Ušetřili jste ()
                   
                  Vyžádat nacenění
                  Description
                  OverviewA 21-amino acid polypeptide with potent vasoconstrictive action. Produces convulsions, arterial hypertension, and metabolic activation of periventricular white and gray matter. Its effects are mediated via L-type Ca2+ channels. Reported to activate phospholipase C in fibroblasts expressing ETA receptors.
                  Catalogue Number05-23-3800
                  Brand Family Calbiochem®
                  SynonymsET-1, CSCSSLMDKECVYFCHLDIIW
                  References
                  ReferencesCesari, M., et al. 1996. Am. Heart J. 132, 1236.
                  Gresser, O., et al 1996. Biochem. Biophys. Res. Commun. 224, 169.
                  Murata, S., et al. 1995. J. Pharmacol. Exp. Ther. 274, 1524.
                  Hexum, T.D., et al. 1990. Biochem. Biophys. Res. Commun. 167, 294.
                  Itoh, Y., et al. 1988. FEBS Lett. 231, 440.
                  Yanagisawa, M., et al. 1988. Nature 332, 411.
                  Product Information
                  CAS number117399-94-7
                  ATP CompetitiveN
                  FormWhite to off-white solid
                  FormulationSupplied as an acetate salt.
                  Hill FormulaC₁₀₉H₁₅₉N₂₅O₃₂S₅
                  Chemical formulaC₁₀₉H₁₅₉N₂₅O₃₂S₅
                  ReversibleN
                  Sold on the basis of peptide contentY
                  Applications
                  Biological Information
                  Primary TargetPotent vasoconstrictive action
                  Purity≥96% by HPLC
                  Physicochemical Information
                  Cell permeableN
                  Peptide ContentY
                  Peptide SequenceH-Cys¹-Ser-Cys³-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys¹¹-Val-Tyr-Phe-Cys¹⁵-His-Leu-Asp-Ile-Ile-Trp-OH (disulfide bonds: 1 → 15; 3 → 11)
                  Dimensions
                  Materials Information
                  Toxicological Information
                  Safety Information according to GHS
                  Safety Information
                  Product Usage Statements
                  Storage and Shipping Information
                  Ship Code Ambient Temperature Only
                  Toxicity Standard Handling
                  Storage -20°C
                  Protect from Moisture Protect from moisture
                  Do not freeze Ok to freeze
                  Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 weeks at -20°C.
                  Packaging Information
                  Transport Information
                  Supplemental Information
                  Specifications

                  Documentation

                  MSDS

                  Title

                  Safety Data Sheet (SDS) 

                  Certificates of Analysis

                  TitleLot Number
                  05-23-3800

                  References

                  Přehled odkazů
                  Cesari, M., et al. 1996. Am. Heart J. 132, 1236.
                  Gresser, O., et al 1996. Biochem. Biophys. Res. Commun. 224, 169.
                  Murata, S., et al. 1995. J. Pharmacol. Exp. Ther. 274, 1524.
                  Hexum, T.D., et al. 1990. Biochem. Biophys. Res. Commun. 167, 294.
                  Itoh, Y., et al. 1988. FEBS Lett. 231, 440.
                  Yanagisawa, M., et al. 1988. Nature 332, 411.
                  Data Sheet

                  Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

                  Revision12-May-2008 JSW
                  SynonymsET-1, CSCSSLMDKECVYFCHLDIIW
                  DescriptionA 21 amino acid polypeptide with potent vasoconstrictive action. Produces convulsions, arterial hypertension, and metabolic activation of periventricular white and gray matter. Its effects are mediated via L-type Ca2+ channels. Reported to activate phospholipase C in fibroblasts expressing ETA receptors.
                  FormWhite to off-white solid
                  FormulationSupplied as an acetate salt.
                  CAS number117399-94-7
                  Chemical formulaC₁₀₉H₁₅₉N₂₅O₃₂S₅
                  Peptide SequenceH-Cys¹-Ser-Cys³-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys¹¹-Val-Tyr-Phe-Cys¹⁵-His-Leu-Asp-Ile-Ile-Trp-OH (disulfide bonds: 1 → 15; 3 → 11)
                  Purity≥96% by HPLC
                  Solubility5% Acetic acid (0.5 mg/ml). Dissolve peptide initially at 8 mg/ml in 80% cold acetic acid, then dilute with distilled water to achieve 5% acetic acid and 0.5 mg/ml peptide.
                  Storage -20°C
                  Protect from moisture
                  Do Not Freeze Ok to freeze
                  Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 2 weeks at -20°C.
                  Toxicity Standard Handling
                  ReferencesCesari, M., et al. 1996. Am. Heart J. 132, 1236.
                  Gresser, O., et al 1996. Biochem. Biophys. Res. Commun. 224, 169.
                  Murata, S., et al. 1995. J. Pharmacol. Exp. Ther. 274, 1524.
                  Hexum, T.D., et al. 1990. Biochem. Biophys. Res. Commun. 167, 294.
                  Itoh, Y., et al. 1988. FEBS Lett. 231, 440.
                  Yanagisawa, M., et al. 1988. Nature 332, 411.